Transfusion requirements during continuous veno-venous haemofiltration: - The importance of filter life

Intensive Care Medicine

Volumn 26, Issue 11, 2000, Pages 1694-1697

  Cutts, Mark W J ^a   Thomas, Antony N ^a   Kishen, Roop ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

Blood transfusion; Haemofiltration; Intensive care; Veno venous haemofiltration

Indexed keywords

HEPARIN; PROSTACYCLIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; CLINICAL ARTICLE; DEVICE; FEMALE; HEMOFILTRATION; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTENSIVE CARE; LENGTH OF STAY; MALE; SCORING SYSTEM;

BLOOD COAGULATION; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HEMOFILTRATION; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 0033647461     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340000676     Document Type: Article

References (13)

1. Effect of blood transfusion on post-operative immunocompetence
2. A Canadian survey of transfusion practices in critically ill patients
3. Relationship between post-operative anaemia and cardiac morbidity in high-risk vascular patients in the intensive care unit
4. A multicenter randomized controlled clinical trial of transfusion requirements in critical care
5. Blood conservation - A critical care imperative
6. Blood conservation in critical care - The evidence accumulates
7. Use of a blood conservation device in critical care
8. Serum concentrations and clearances of folic acid and pyridoxal-5'-phosphate during veno venous continuous renal replacement therapy
9. RBC transfusion in the ICU: Is there a reason?
10. Erythropoietin in patients with acute renal failure and continuous veno venous haemofiltration
11. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anaemia of medical intensive care patients
12. APACHE II: A severity of disease classification system
13. Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial